Consumer Defensive
Zhong Yuan Bio-Technology Holdings Limited(ZHYBF)
Live Price
Offline$2.02
+0.00% today
1Y Change
+1.00%
Window
Jun 23, 2025 → Jun 12, 2026
- Market Cap
- $40.00M
- Revenue Growth
- +37.0%
- EPS Growth
- +114.2%
- Dividend Yield
- 0.0%
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is a Consumer Defensive stock with a market cap of $40.00M and listed on OTC. The stock last traded around $2.02 and up 1.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +37.0%, EPS growth of +114.2%, a dividend yield of 0.0%. What stands out right now is revenue +37.0%, EPS +114.2%, free cash flow +27.0% with operating margin 11.7% and ROIC 10.1%. Valuation already assumes a fairly strong business story at P/E 118.6 and price/sales 15.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZHYBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+37.0% vs +1.7% peer median
Operating Margin
Above sector median
+11.7% vs +6.6% peer median
P/E
Above sector median
118.6 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +37.0% and EPS at +114.2%, with operating margin around 11.7%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZHYBF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZHYBF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZHYBF and SPY.
Company Overview
Zhong Yuan Bio-Technology Holdings Limited
Other OTC
Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Wanchai, Hong Kong.
- Leadership
- Ting Ting Chang
- IPO Date
- Jun 4, 2021
- Employees
- 23
- Street Address
- Tesbury Centre
- Mailing
- Wan Chai
- Region
- Wan Chai, HK
- Reporting Currency
- USD
- Investor Line
- 852 2919 8916
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 118.6
- EV/EBITDA
- 80.5
- Price/Sales
- 15.7
- Price/Book
- —
Growth
- Revenue
- +37.0%
- EPS
- +114.2%
- Free Cash Flow
- +27.0%
Profitability
- Gross Margin
- 90.9%
- Operating Margin
- 11.7%
- Net Margin
- 13.3%
- ROE
- -109.7%
- ROIC
- 10.1%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.82
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.